Results 251 to 260 of about 2,358,049 (278)

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease.

Metabolism: Clinical and Experimental, 2015
Lingzhi Li, Lijia Chen, J. Zang, Xi Tang, Yan Liu, Jie Zhang, Lin Bai, Q. Yin, Yanrong Lu, Jingqiu Cheng, P. Fu, Fang Liu   +11 more
semanticscholar   +1 more source

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

C5a receptor

2009
openaire   +1 more source

Breast cancer statistics, 2019

Ca-A Cancer Journal for Clinicians, 2019
Carol E Desantis, Jiemin, Mia M Gaudet
exaly  

C5a receptor

2011
openaire   +1 more source

C5a receptor

2006
openaire   +1 more source

Evolving standards of care and new challenges in the management of HER2‐positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Grace M Choong, Grace D Cullen, Ciara C O'sullivan   +2 more
exaly  

C5a Receptors

2015
openaire   +1 more source

Breast cancer statistics, 2017, racial disparity in mortality by state

Ca-A Cancer Journal for Clinicians, 2017
Carol E Desantis, Ann Goding Sauer Msph, Lisa A Newman   +2 more
exaly